Cas9 activates the p53 pathway and selects for p53-inactivating mutations-Reference-Cited by-同舟云学术

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Published:2020-05-18 Issue:7 Volume:52 Page:662-668
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Enache Oana M.,Rendo Veronica^ORCID,Abdusamad Mai,Lam Daniel,Davison Desiree,Pal Sangita,Currimjee Naomi,Hess Julian,Pantel Sasha,Nag Anwesha,Thorner Aaron R.,Doench John G.^ORCID,Vazquez Francisca,Beroukhim Rameen^ORCID,Golub Todd R.^ORCID,Ben-David Uri^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/s41588-020-0623-4.pdf

Reference38 articles.

1. Ben-David, U., Beroukhim, R. & Golub, T. R. Genomic evolution of cancer models: perils and opportunities. Nat. Rev. Cancer 19, 97–109 (2019).

2. Ben-David, U. et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560, 325–330 (2018).

3. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).

4. Jinek, M. et al. RNA-programmed genome editing in human cells. eLife 2, e00471 (2013).

5. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics analysis reveals that Cas13d contributes to PI3K-AKT signaling and facilitates cell proliferation via PFKFB4 upregulation;Gene;2024-11

2. Pervasive expostulation of p53 gene promoting the precipitation of neurogenic convulsions: A journey in therapeutic advancements;European Journal of Pharmacology;2024-11

3. Stepwise de novo establishment of inactive X chromosome architecture in early development;Nature Genetics;2024-09-10

4. Recent progress in gene therapy for familial hypercholesterolemia treatment;iScience;2024-09

5. Nucleic Acid Therapy for the Skin;Journal of Investigative Dermatology;2024-09